Download Xylocaine: a new topical anesthetic in urology

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Bad Pharma wikipedia , lookup

History of general anesthesia wikipedia , lookup

Transcript
- -,y
THE Jomm.u. oF URoLOGY
Vol. 62, No. 6, December 1949
Printed in U.S.A.
USE IN THE FEMALE
XYLOCAINE: A NEW TOPICAL ANESTHETIC IN URQLOGY1
L C. PRICE
"J,T:g,
J. S. HAINES
s. c.
AND
HARRY GRABSTALD.
· From United States Marine Hospital, Baltimore, Md .
.eck thoroughly the urethra
eatment. We have customunds available were of the
:sary for each case.
~. 26 and 28F, could be inlbs sufficiently far apart to
.d give us one . small ' con.dily available· and which
important test.
months and find it very
• the urologist's armamen. urethral strictures which
: technique advocated by
t of the cases.
·,,
Several months ago the urology service at this hospital began to investigate
a new anesthetic drug. This new drug called Xylocaine (diethylamino-2:6
diethylacetanalide) was first described by Lofgren and Lundquist of Sweden and
its pharmacologica.l properties were studied by Goldberg, who compared it with
procaine and tet:rocaine as to toxicity; action on blood pressure, anesthetic qualities, including its use as a topical anesthetic, and local irritant action. He concluded that Xylocaine showed high degrees of anesthetic potency both for
surface and infiltration purposes and that it displayed a con;tbination of phar·
macological properties which strongly urged its us~ for clinical purposes.
,Of the many qualities desirable in an anesthetic, including low toxicity and
effective interruption of painful st:iilluli, rapidity of action is especially important to the urologist who would prefer to be able to do cystoscopy without having
to wait for long periods of time, while an anesthetic agent is taking effect. We
.
believe that Xylocaine has these favorable attributes.
We have used Xylocaine in a 2 per cent solution as a topical anesthetic for
transurethral procedures varying from mere passage of sounds to cystoscopy
with extensive fulguration o{bladder papillomas. Our results have been highly
satisfactory and we have noted no untoward reactions. Approximately 10 cc
are used for each cystoscopy except in .females in whom Xylcicaine soaked applicator sticks have been successfully used. It is extremely difficult to evaluate an
anesthetic agent in cystoscopy wherein so much depends upon subjective differences as well as upon the technique and .skill of the operator. In our series of
250 cases, we have made a special point of including those patients who had
had previous cystoscopy either at this hospital or elsewhere when Xylocaine
was not used.· Almost without exception, these. patients have expressed a definite preference for the procedure in which Xylocaine was used. In many instances the same operator had occasion to examine these patients with and without the benefit of Xylocaine and the results were rather dec:lsiv~ in favor of this
agent.
Several cases in our series are worthy of mention. One 75 year old physician
who had had recurrent bladder papillomas fulglirated at regular intervals under
spinal anesthesia entered the hospital for treatment and refused spinal on this
occasion. Highly satisfactory anesthesia was obtained using Xylocaine and approximately 15 bladder papillomas were fulgurated successfully. Two veterans
who had suffered straddle injuries and ruptured urethras during the war have
been coming to this hospital at regular intervals for urethraldilatations for
several years. These men have both reported a definite difference and imp~ove­
ment following use of Xylocaine..
• The Xylocaine used in this study was furnished by Mr. Erik Bjaringer of the Astra
Pharmaceutical Products.
·
901
902
J. S. HAINES AND HARRY GRABSTALD
Without exception definite subjective differences have been noted in r:ln''"'·'~
whom cystoscopy is done with Xylocaine on one occasion and with other'·u,JtJl•~~:~.r
anesthetics on others.
:'.~., .. ~. ·
Allion, G. and Robbins, M. A. Pri
Several months ago un\ler the Section titled Queries and Minor Notes .in'hthe. ~ :
An unusual complication . of
Journal of the American Medical Association a physidan reported on the use:'of .
.
·urethral prostatic resectio~, 3~8
"Zylcaine" in local anesthesia. This product is stated\ "to contain in each cc p~o:~.,
. Adams, J: R., see P. Nowhn, Jt
caine base, 0.075 gm.; Butyl aminobenzoate, 0.3 gm.; and benzyl alcohol ·oi25
..
Adrenal, .medulla, pheochromocytom
.
.
' _.
new growths, corte.x, 639 .
gm., dissolved in peanut oil." This material is a long lasting anesthetic whick
new growths, phechromocytoma,!
has apparently produced· some local untoward reactions. This agent is not. the::
Allen, H. N., see G. Carroll, jt. aut}
· one· described in this paper. The similarities in names justifies this brief comme~t~ ~>::
Alyea, E. p. and Rundles! R. V\
T·
••
"-
.
marrow studies in carcmoma 1
tate;332
.
Amberson, J. B., see J. K. Lattr
auth.
.
American Cystoscope Makers, Inc
resectoscope, 381
Vest· cystoscope for dilatation P
378
.
American Urological ASsociation, N
land Section, fall meeting, 790
New York Section, program of
638
'
North Central Section, program
ing, 400
Northeastern Section, program
ing, 265
present organization, 799
presidential address·1949, 799
South Central Section, program
ing, 402
·
Anesthesia, local, !or transureth:
tion, 231
.
.
Anesthetic, urethral, intracame
89
xylocaine, 901
Anomaly, see various organs and >
Arcadi, J. A. and Farman, F. Exi
studies and clinical aspects
circulation, 756 .
Arduino, L. J., see E. Baron,_ it.:.
Arnkoff, M., see F. E, RuboVIts,:
Ascites, 30
. .
Aureomycin, urinary tract mfec
594
Aycock, L. Medical managemeJ
mature ejaculation, 361
Bailey, M. K., Fort, C. A. and H!
Papillary carcinoma of urete
der arising after nephrectom:
of kidney pelvis, 44